Clinical Trials · NCT07303556
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Nazarbayev University
- Enrollment
- 120
- Start date
- Dec 2024
- Locations
- 1 site, Kazakhstan
- Primary endpoint
- Change in NT-proBNP levels from baseline to Week 24